During the past decade, Clinical Research of South Florida conducted 68 clinical trials. In the 10-year time frame, 68 clinical trials started and 54 clinical trials were completed, i.e. on average, 79.4% percent of trials that started reached the finish line to date. In the past 5 years, 26 clinical trials started and 35 clinical trials were completed. i.e. 134.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinical Research of South Florida" #1 sponsor was "Eli Lilly and Company" with 14 trials, followed by "Pfizer" with 13 trials sponsored, "AstraZeneca" with 4 trials sponsored, "Gilead Sciences" with 4 trials sponsored and "Janssen Vaccines & Prevention B.V." with 4 trials sponsored. Other sponsors include 70 different institutions and companies that sponsored additional 65 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinical Research of South Florida" #1 collaborator was "Athenex, Inc." with 2 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Iqvia Pty Ltd" with 2 trials as a collaborator and "Syneos Health" with 2 trials as a collaborator. Other collaborators include 15 different institutions and companies that were collaborators in the rest 24 trials.

According to Clinical.Site data, the most researched conditions in "Clinical Research of South Florida" are "Type 2 Diabetes Mellitus" (7 trials), "Influenza" (6 trials), "Type 2 Diabetes" (6 trials), "Hypertension" (5 trials) and "HIV Infections" (4 trials). Many other conditions were trialed in "Clinical Research of South Florida" in a lesser frequency.

Most popular intervention types in "Clinical Research of South Florida" are "Drug" (83 trials), "Biological" (24 trials), "Other" (10 trials), "Device" (6 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (50 trials), "Tirzepatide" (4 trials), "Dulaglutide" (3 trials), "LY3556050" (3 trials) and "placebo" (3 trials). Other intervention names were less common.

The vast majority of trials in "Clinical Research of South Florida" are 104 trials for "All" genders, 5 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Clinical Research of South Florida". undefined are not yet recruiting, 3 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 92 completed trials in Clinical Research of South Florida, 1 suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Clinical Research of South Florida, 4 "Phase 1" clinical trials were conducted, 40 "Phase 2" clinical trials and 57 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 5 trials that are defined as “Not Applicable".